Title:
DUAL TARGETING ANTIGEN BINDING MOLECULE
Document Type and Number:
WIPO Patent Application WO/2020/062155
Kind Code:
A1
Abstract:
Provided is a dual targeting antigen binding molecule, a pharmaceutical composition comprising the dual targeting antigen binding molecule and the uses thereof for the treatment of diseases. Also Provided is a method for producing the dual targeting antigen binding molecule.
Inventors:
WANG SHAOXIONG (CN)
ZHAO JING (CN)
HUANG LIMING (CN)
WANG MING (CN)
XU JUEHUA (CN)
XU JOHN L (CN)
ZOU SHANSHAN (CN)
ZHAO JING (CN)
HUANG LIMING (CN)
WANG MING (CN)
XU JUEHUA (CN)
XU JOHN L (CN)
ZOU SHANSHAN (CN)
Application Number:
PCT/CN2018/108700
Publication Date:
April 02, 2020
Filing Date:
September 29, 2018
Export Citation:
Assignee:
MAB LEGEND BIOTECH CO LTD (CN)
International Classes:
A61K39/395; C07K16/46; A61P35/00; C12N15/00; C12N15/13; C12P21/08
Foreign References:
| CN103476795A | 2013-12-25 |
Other References:
SPIESS, CHRISTOPH ET AL.: "Alternative molecular formats and therapeutic applications for bispecific antibodies", MOLECULAR IMMUNOLOGY, vol. 67, no. 2, 31 October 2015 (2015-10-31), pages 95 - 106, XP029246892
KLEIN, CHRISTIAN ET AL.: "Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies", MABS, vol. 4, no. 6, 1 November 2012 (2012-11-01), pages 653 - 663, XP009170958
See also references of EP 3856788A4
KLEIN, CHRISTIAN ET AL.: "Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies", MABS, vol. 4, no. 6, 1 November 2012 (2012-11-01), pages 653 - 663, XP009170958
See also references of EP 3856788A4
Attorney, Agent or Firm:
BEIJING CAI HE LAW FIRM (CN)
Download PDF: